[UltraGen-KY] Announcement Regarding Board Resolution to Waive Non-Compete Restrictions for Directors

1. Date of Shareholders' Meeting: June 4, 2026 2. Directors permitted to engage in competitive behavior: Corporate Director: Bora Pharmaceuticals (Representative: Mr. Sheng Pao-Hsi) Corporate Director: Delos Capital Fund, LP (Representative: Mr. Chen Lin-Cheng) Corporate Director: Peng-Lin Investment Co., Ltd. (Representative: Mr. Chen Chih-Chuan) Corporate Director: Allen Chao and Lee Hwa Chao Family Trust (Representative: Dr. Allen Chao) Independent Director: Mr. Wang Tai-Chang Independent Director: Ms. Chang Yen-Shu Independent Director: Mr. Tseng Chih-Yang 3. Items permitted: Investing in or managing companies with the same or similar business scope as the Company. 4. Period of permission: During their term of office as directors of the Company. 5. Voting results (pursuant to Article 209 of the Company Act): Approved at the June 4, 2026 Annual General Meeting with votes exceeding the statutory threshold. 6. Directors engaged in mainland China business: Not applicable. 7. Other matters: None.